Histacross 180mg Tablet
Marketer
Amwill Healthcare
Salt Composition
Fexofenadine (180mg)
Overview Histacross 180mg Tablet
Aller-Ease 180mg tablets offer relief from allergy symptoms including nasal congestion, sneezing, itching, watery eyes, and swelling. This medication also effectively manages itchy, red, or swollen skin related to allergies. Administer Aller-Ease 180mg as prescribed by your physician, with or without food. Dosage depends on individual response and condition. Continue treatment as directed; do not discontinue use without consulting your doctor. Common, typically transient, side effects include headache, drowsiness, dizziness, and nausea. Persistent or concerning side effects warrant medical attention. Avoid self-treating or recommending this medication to others. Always seek professional medical advice for optimal results. Patients with kidney, liver, or heart conditions, as well as pregnant or breastfeeding individuals, must consult their physician before use.
Uses of Histacross 180mg Tablet
Managing allergic rhinitis symptoms, including sneezing and nasal discharge.
Major Benefits of Histacross 180mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Histacross 180mg Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Histacross 180mg Tablet:
- Headache
- Drowsiness
- Dizziness
- Nausea
How to use Histacross 180mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Histacross 180mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Histacross 180mg Tablet works:
Histacross 180mg tablets are classified as antihistamines. They counteract the body's histamine release during allergic reactions, thereby reducing the immune system's response.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Histacross 180mg Tablet is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Histacross 180mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Histacross 180mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant. The low concentration in breast milk and absence of drowsiness suggest no negative consequences for breastfed babies.
DrivingSAFE
Driving ability is typically unaffected by Histacross 180mg Tablets. Nevertheless, prior to driving or operating equipment, confirm that you do not experience drowsiness or dizziness after taking Histacross 180mg Tablets.
KidneyCAUTION
Individuals with kidney impairment should use Histacross 180mg tablets cautiously. Dosage modification for Histacross 180mg tablets might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Individuals with liver conditions can safely use Histacross 180mg tablets without altering the prescribed dosage. Nevertheless, parental administration of fexofenadine to children with severe hepatic impairment requires prior medical consultation.
What if you forget to take Histacross 180mg Tablet :
Remember to take a missed dose immediately upon recollection, unless your physician has instructed otherwise. However, omit the missed dose if your next scheduled dose is imminent. Avoid doubling up on doses; always adhere precisely to your prescribed medication schedule.
Facts to Know About Histacross 180mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Benzhydryl compound |
| Potential for Dependence | None. |
| Medication Category | Breathing-related |
| Mechanism of Action | Second-generation H1-receptor antagonists |



